Narinder Pal Singh

Narinder Pal Singh

Auto-generated profile, based on publicly available information

Narinder Pal Singh

Department of Anesthesia and Pain Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
NSNarinder P. Singh
Narinder P. Singh
JMJeetinder K. Makkar
Jeetinder K. Makkar
JCJaneesha K. Chawla
Janeesha K. Chawla
RSRakesh Sondekoppam
Rakesh Sondekoppam
PSPreet M. Singh
Preet M. Singh

1 December 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JMJeetinder K. Makkar
Jeetinder K. Makkar
NSNarinder P. Singh
Narinder P. Singh
NBNidhi Bhatia
Nidhi Bhatia
TSTanvir Samra
Tanvir Samra
PSPreet Mohinder Singh
Preet Mohinder Singh


15 October 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
MKMuthuraj Kanakaraj
Muthuraj Kanakaraj
ABAdithya D. Bhat
Adithya D. Bhat
NSNarinder P. Singh
Narinder P. Singh
SBSennaraj Balasubramanian
Sennaraj Balasubramanian
ATAbhay Tyagi
Abhay Tyagi
PSPreet M. Singh
Preet M. Singh

10 February 2025 in Anaesthesia
Verified
Journal Article
Closed access
JMJeetinder K. Makkar
Jeetinder K. Makkar
NSNarinder Pal Singh
Narinder Pal Singh
BKBisman J. K. Khurana
Bisman J. K. Khurana
JCJaneesha K. Chawla
Janeesha K. Chawla
PSPreet M. Singh
Preet M. Singh

19 December 2022 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
NSNarinder P Singh
Narinder P Singh
JMJeetinder Kaur Makkar
Jeetinder Kaur Makkar
ABAnuradha Borle
Anuradha Borle
PSPreet Mohinder Singh
Preet Mohinder Singh
Background/importance: Postoperative neurocognitive dysfunction (PNCD) is a frequent and preventable complication after surgery. The large high-quality evidence for the efficacy of supplemental regional analgesia blocks (RAB) for preventing PNCD is still elusive.Objective: The objective of this meta-analysis was to evaluate the effect of RAB versus standard anesthesia care on the incidence of PNCD in adult patients undergoing major non-cardiac surgery.Evidence review: PubMed, EMBASE, Scopus, and the Cochrane Central Registers of Controlled Trials (CENTRAL) were searched for randomized controlled trials (RCTs) from 2017 until June 2022. The primary outcome was the incidence of PNCD within 1 month of surgery. A random-effects model with an inverse variance method was used to pool results, and OR and mean differences were calculated for dichotomous and continuous outcomes. Various exploratory subgroup analyses were performed to explore the possibility of the association between the various patient, technique, and surgery-related factors. Grading of Recommendation, Assessment, Development, and Evaluation guidelines were used to determine the certainty of evidence.Findings: Twenty-six RCTs comprizing 4414 patients were included. The RAB group was associated with a significant reduction in the incidence of PNCD with an OR of 0.46 (95% CI 0.35 to 0.59; p<0.00001; I2=28%) compared with the control group (moderate certainty). Subgroup analysis exhibited that the prophylactic efficacy of RAB persisted for both delirium and delayed neurocognitive recovery.Conclusions: Current evidence suggests that supplemental RAB are beneficial in preventing PNCD in patients after major non-cardiac surgery.PROSPERO registration number: CRD42022338820